Katayama Y, Yamada T, Sawada R, Kawachi H, et al. Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer. Oncologist 2024 Jan 18:oyae001. doi: 10.1093.
PMID: 38241181